Fig. 1From: HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patientsDiagnostic performance of CA125, HE4 and ROMA for detection of ovarian cancer in premenopausal (A) and postmenopausal (B) patientsBack to article page